A boy aged 6 months who presented with poor weight gain, diarrhoea, and infection with Pneumocystis carinii was found to have congenital hypogammaglobulinaemia, which did not improve despite monthly treatment with intravenous gammaglobulin. At the age of 3 years and 2 months he developed severe vomiting and diarrhoea due to cryptosporidiosis, which failed to respond to conventional treatment. Infusion of hyperimmune bovine colostrum produced against parasite antigen, given by nasogastric tube, was started after symptoms had persisted for three weeks. His vomiting and diarrhoea resolved within five days of treatment, and oocysts were no longer seen in the stools after eight days. Later, however, he developed a rare complication, and oocysts were found in the common bile duct.
Introduction
Cryptosporidiosis is a major problem in the management of immunologically compromised patients and may lead to chronic malabsorption and severe weight loss. Infections in immunodeficient patients were reported first in patients with hypogammaglobulinaemiia' 2; more recently cryptosporidiosis has become important in patients with the acquired immune deficiency syndrome.3 Chemotherapeutic drugs such as spiramycin have generally proved ineffective. 4 We describe remission of diarrhoea due to cryptosporidiosis after treatment with hyperimmune bovine colostrum in a child with hypogammaglobulinaemia.
Case report
The patient first presented at the age of 6 months with poor weight gain, diarrhoea of two months' duration, and pneumonia due to Pneumocystis carinuz. His serum IgG concentration was 0-52 g/I (third percentile for 6 months of age= The hyperimmune colostrum was prepared by immunising two pregnant dairy cows 10 weeks before calving either with Percoll purified whole oocysts' or with sporozoites that were excysted by treatment with trypsin and bile salts from Percoll purified oocysts. The cows were given 2 ml intramuscular injections of about 10' intact or excysted oocysts/ml ( 4 x 10' sporozoites/ml), mixed with an equal volume of Freund's complete adjuvant. Two weeks later they were reimmunised by intramammary infusion into each quarter with the same antigens mixed with an equal volume of Freund's incomplete adjuvant. The cows were milked immediately after parturition, and the colostrum was stored at -20'C. Samples of colostrum from both cows on the second day after parturition were mixed in equal volumes before use. Challenge of specific pathogen free mice with a mixture of excysted oocysts and a 1:10 dilution of heated hyperimmune colostrum (at 56'C for 30 minutes) showed complete protection from infection, whereas infection occurred at nine days in mice challenged with oocysts and heated non-immune colostrum and at four days in mice challenged with oocysts alone.
Microbiological assays of the colostrum showed only 25 colony forming units of bacteria of bovine origin (Streptococcus spp and lactose fermenters) per ml of colostrum. The patient received 200 ml of untreated hyperimmune colostrum mixed with 800 ml Digestalac given daily at a rate of 45 ml/h by nasogastric tube for 12 days. He then received 50 ml of colostrum orally for four days. Vomiting stopped three days after treatment was begun, and the watery diarrhoea resolved after five days. Sequential examination of faeces showed a decrease in the numbers of oocysts after two days of treatment; oocysts had disappeared completely within eight days and were not detected again. When he was discharged, 20 days after treatment was begun, he was well, had a good appetite, and was passing one to three semiformed stools daily and his weight had returned to normal. During the four months after treatment he had no further diarrhoea and his stools were free of cryptosporidium oocysts. Recent investigations after a transient rise in concentration of hepatic enzymes, however, showed dilatation of the bile duct with oocysts in fluid aspirated directly from the common bile duct.
Discussion
In two children with congenital hypogammaglobulinaemia and cryptosporidiosis described previously diarrhoea persisted despite exhaustive treatment with various chemotherapeutic drugs. One child had chronic diarrhoea that lasted for four years and remained unresolved,2 and a second child, who also had hypogammaglobulinaemia with raised IgM concentrations, died after protracted diarrhoea lasting six years. 2 After our patient was treated with hyperimmune bovine colostrum faeces were found to be free of oocysts and diarrhoea stopped. The major secretary immunoglobulin in the cow is IgGl, which fulfils the same role in ruminants as IgA does in monogastric species by being resistant to low pH and luminal proteolysis.6 Colostrum is therefore more likely to be effective when administered orally than is purified bovine serum IgG. Experiments in mice showed a protective effect of heated hyperimmune colostrum on challenge with cryptosporidium oocysts, suggesting that neutralising activity was present. The colostrum was effective in our patient when given without the use of histamine antagonists or antacids.
Two issues warrant further investigation: the usefulness of this treatment in patients with T lymphocyte dysfunction, and whether colostrum from non-immunised cows is effective when it is used in larger volumes. As cryptosporidiosis is very common in bovine species ordinary colostrum from some cows may be effective. Hyperimmune bovine colostrum is safer than most drugs, which is a consideration when treating debilitated patients, and, should microbial contamination of colostrum pose a problem in immunodeficient individuals, it could be gamma irradiated without affecting the immunoglobulin concentration. Hyperimmune bovine colostrum appears to be a useful adjunct in the treatment of diarrhoea due to infection with cryptosporidium in patients with immunodeficiency disorders, particularly those in whom treatment with antibiotics has failed. In this patient, however, the rare complication of ascending biliary tract infection was not prevented. Percoll He was subsequently found to have fixed splitting of the second heart sound and a pulmonary systolic murmur. Cardiac catheterisation confirmed the presence of a secundum atrial septal defect. The ratio of pulmonary to systemic flow was 3:1. Valsalva's manoeuvre, oxygen breathing, and straight leg raising all produced bidirectional shunting, confirmed by dye dilution. There was no right to left component to the shunt while he was supine and breathing air. The atrial septal defect was corrected surgically, and he was advised not to dive.
Comment
Pulmonary barotrauma and decompression sickness may result from the ascent after a dive.2 Decompression sickness results from the release of bubbles of nitrogen from solution as pressure is reduced. Unless large and rapid changes in pressure occur the symptoms and signs of decompression sickness develop over several hours. The dive performed was only just long enough to require decompression stops according to the air diving decompression table of the Royal Navy Physiological Laboratory and British SubAqua Club. Failure to perform stops placed the divers at risk of developing decompression sickness. The paraplegia that developed six hours after the dive was typical ofdecompression sickness, though the early symptoms were aot.
Syncope immediately after surfacing as well as unilateral and unimodal neurological symptoms are characteristic of arterial gas embolism, not decompression sickness.2 Arterial gas embolism is usually the result of air embolism due to pulmonary barotrauma, but no cause for this was found. After all dives nitrogen bubbles are formed in the venous system3 but are trapped in the pulmonary capillaries without producing symptoms. In this patient the embolus was probably not air from pulmonary barotrauma but paradoxical embolism of venous nitrogen bubbles.
Although Initial investigations showed a haemoglobin concentration of 129 g/l and a white blood cell count of 28-5 x 109/1 with neutrophiliA. Plasma electrolyte concentrations were: sodium 134 mmol (mEq)/l, potassium 2-5 mmol (mEq)/l, urea 26-3 mmol/l (159 mg/100lml), creatinine 211 imol/l (2-4 mg/l00 ml), and
